These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33607787)

  • 1. Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis.
    Sun KJ; Liu LL; Hu JH; Chen YY; Xu DY
    Medicine (Baltimore); 2021 Feb; 100(7):e24579. PubMed ID: 33607787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
    Johnson TM; Sayles HR; Baker JF; George MD; Roul P; Zheng C; Sauer B; Liao KP; Anderson DR; Mikuls TR; England BR
    Ann Rheum Dis; 2021 Nov; 80(11):1385-1392. PubMed ID: 34049859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
    Westlake SL; Colebatch AN; Baird J; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
    Rheumatology (Oxford); 2010 Feb; 49(2):295-307. PubMed ID: 19946022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis on the efficacy of methotrexate in rheumatoid arthritis.
    Jiang X; Zeng J; Chen F; Li J
    Ann Palliat Med; 2021 Oct; 10(10):10652-10660. PubMed ID: 34763513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis.
    Huang Y; Wang H; Chen Z; Wang Y; Qin K; Huang Y; Ba X; Lin W; Tu S
    Drug Des Devel Ther; 2019; 13():1969-1984. PubMed ID: 31354242
    [No Abstract]   [Full Text] [Related]  

  • 8. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
    Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
    Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical symptoms effect of Tripterygium Glycosides Tablets alone or combined with methotrexate in treatment of rheumatoid arthritis: a Meta-analysis].
    Wang XY; Li TX; Xue ZP; Lyu C; Li HZ; Fan YF; Li YQ; Tian YG; Yang J; Chen WJ; Guo MQ; Wang JX; Wu HY; Zhang YQ; Lin N
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3533-3541. PubMed ID: 31602919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies.
    Xu J; Xiao L; Zhu J; Qin Q; Fang Y; Zhang JA
    Semin Arthritis Rheum; 2022 Aug; 55():152031. PubMed ID: 35671648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of Methotrexate Use on Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients Initiating Biologic Disease-modifying Antirheumatic Drugs.
    Xie F; Chen L; Yun H; Levitan EB; Curtis JR
    J Rheumatol; 2021 Jun; 48(6):804-812. PubMed ID: 33060309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.
    De Vecchis R; Baldi C; Palmisani L
    Anatol J Cardiol; 2016 Jan; 16(1):2-9. PubMed ID: 26467356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of downregulation of serum MMP-3 levels by traditional Chinese medicine ingredients combined with methotrexate on the progression of bone injury in patients with rheumatoid arthritis: A protocol for a systematic review and meta-analysis.
    Sun Y; Huang Y; Chen T; Li X; Chen J; Wang Z; Lin K; Gao Y; He L
    Medicine (Baltimore); 2020 Oct; 99(43):e22841. PubMed ID: 33120813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Jobanputra P; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Kynaston-Pearson FJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD007649. PubMed ID: 25231904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
    Feng ZT; Xu J; He GC; Cai SJ; Li J; Mei ZG
    Clin Rheumatol; 2018 Jan; 37(1):35-42. PubMed ID: 28748514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
    Shao W; Yuan Y; Li Y
    Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.